• 1
    Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS World AIDS Day Report 2011. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS), 2011.
  • 2
    Civitello L. Part IV: Clinical manifestations of HIV infection in children, Chapter 18: Neurologic Problems. In: Zeichner SL, Read JS, editors. Handbook of Pediatric HIV Care (2nd edition). New York, NY: Cambridge University Press, 2006.
  • 3
    Belman AL. Acquired immunodeficiency syndrome and the child's central nervous system. Pediatr Clin North Am 1992; 39: 691714.
  • 4
    Epstein LG, Sharer LR, Oleske JM, et al. Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 1986; 78: 67887.
  • 5
    Faye A, Le Chenadec J, Dollfus C, et al. Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. Clin Infect Dis 2004; 39: 16928.
  • 6
    Chiappini E, Galli L, Tovo PA, et al. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS 2006; 20: 20715.
  • 7
    Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS 2009; 23: 1893901.
  • 8
    Chiriboga CA, Fleishman S, Champion S, Gaye-Robinson L, Abrams EJ. Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART). J Pediatr 2005; 146: 4027.
  • 9
    Rodda JM, Graham HK, Carson L, Galea MP, Wolfe R. Sagittal gait patterns in spastic diplegia. J Bone Joint Surg Br 2004; 86: 2518.
  • 10
    Wren TA, Rethlefsen S, Kay RM. Prevalence of specific gait abnormalities in children with cerebral palsy: influence of cerebral palsy subtype, age, and previous surgery. J Pediatr Orthop 2005; 25: 7983.
  • 11
    Chang FM, Rhodes JT, Flynn KM, Carollo JJ. The role of gait analysis in treating gait abnormalities in cerebral palsy. Orthop Clin North Am 2010; 41: 489506.
  • 12
    Janssen RS, Cornblath DR, Epstein JR, Foa RP. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991; 41: 77885.
  • 13
    Micklesfield LK, Levitt NS, Carstens MT, Dhansay MA, Norris SA, Lambert EV. Early life and current determinants of bone in South African children of mixed ancestral origin. Ann Hum Biol 2007; 34: 64755.
  • 14
    Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 21423.
  • 15
    Graham HK, Harvey A, Rodda J, Nattrass GR, Pirpiris M. The Functional Mobility Scale (FMS). J Pediatr Orthop 2004; 24: 51420.
  • 16
    Greene WB, Heckman JD, editors. The Clinical Measurement of Joint Motion. Rosemont, IL: American Academy of Orthopaedic Surgeons, 1994.
  • 17
    Ashworth B. Prelimimary trial of carisopordol in multiple sclerosis. Practitioner 1964; 192: 5402.
  • 18
    The Guarantors of Brain. Aids to the Examination of the e Peripheral System, Fourth edition. London: W.B. Saunders, 2000: 12.
  • 19
    Novacheck TF, Trost JP, Sohrweide S. Examination of the child with cerebral palsy. Orthop Clin North Am 2010; 41: 46988.
  • 20
    Katz K, Rosenthal A, Yosipovitch Z. Normal ranges of popliteal angle in children. J Pediatr Orthop 1992; 12: 22931.
  • 21
    Delp SL, Arnold AS, Speers RA, Moore CA. Hamstrings and psoas lengths during normal and crouch gait: implications for muscle-tendon surgery. J Orthop Res 1996; 14: 14451.
  • 22
    Fabry G, Macewen GD, Shands AR Jr. Torsion of the femur. A follow-up study in normal and abnormal conditions. J Bone Joint Surg Am 1973; 55: 172638.
  • 23
    Staheli LT, Corbett M, Wyss C, King H. Lower-extremity rotational problems in children. Normal values to guide management. J Bone Joint Surg Am 1985; 67: 3947.
  • 24
    Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008; 359: 223344.
  • 25
    Cotton MF, Violari A, Otwombe K, et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet 2013. Epub August 22.
  • 26
    Langerak NG, Tam N, Vaughan CL, Fieggen AG, Schwartz MH. Gait status 17-26 years after selective dorsal rhizotomy. Gait Posture 2012; 35: 2449.
  • 27
    Magee DJ. Chapter 9: Lumbar spine. In: Majee DJ, editor. Orthopaedic Physical Assessment (5th edition). St Louis, MO: Saunders Elsevier, 2008: 515616.
  • 28
    Hilburn N, Potterton J, Stewart A. Paediatric HIV encephalopathy in sub-Saharan Africa. Phys Ther Rev 2013; 15: 4107.